During the past decade, University Surgical Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Surgical Associates" #1 sponsor was "C. R. Bard" with 2 trials, followed by "Spectranetics Corporation" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Cardiovascular Systems Inc" with 1 trials sponsored and "Horizons International Peripheral Group" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Surgical Associates" #1 collaborator was "Advanced Catheter Therapies, Inc." with 1 trials as a collaborator, "Bard Ltd" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University Surgical Associates" are "Peripheral Arterial Disease" (3 trials), "ABDOMINAL AORTIC ANEURYSMS" (1 trials), "Arteriovenous Fistula" (1 trials), "Arteriovenous Fistula Occlusion" (1 trials) and "Arteriovenous Fistula Stenosis" (1 trials). Many other conditions were trialed in "University Surgical Associates" in a lesser frequency.

Most popular intervention types in "University Surgical Associates" are "Device" (8 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "AneuRx AAA stent graft / Talent AAA stent graft" (1 trials), "Cardiovascular Ingenuity (CVI) Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter" (1 trials), "ELUVIA (Stent Implantation)" (1 trials), "EverCross Percutaneous Transluminal Balloon Catheter" (1 trials) and "EverCross™ 0.035 PTA Balloon Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Surgical Associates" are 10 trials for "All" genders.

Currently, there are NaN active trials in "University Surgical Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University Surgical Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Surgical Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".